1. Fracture Risk Reduction by Bisphosphonates in Mastocytosis?

   Onnes, M. C., van Doormaal, J. J., van der Veer, E., Versluijs, J. B., Arends, S. & Elberink, H. N. G. O., 2020, In : Journal of Allergy and Clinical Immunology: In Practice. 8, 10, p. 3557-3564 8 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis

   Arends, S., Wink, F., Veneberg, J., Bos, R., van Roon, E., van der Veer, E., Maas, F. & Spoorenberg, A., 5-Jul-2020, In : British Journal of Clinical Pharmacology. 8 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-alpha inhibitors

   Carbo, M. J. G., Spoorenberg, A., Maas, F., Brouwer, E., Bos, R., Bootsma, H., van der Veer, E., Wink, F. & Arends, S., 24-Apr-2018, In : PLoS ONE. 13, 4, 12 p., e0196281.

   Research output: Contribution to journal › Article › Academic › peer-review

4. A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates

   van den Berg, P., van Haard, P. M. M., van der Veer, E., Geusens, P. P., van den Bergh, J. P. & Schweitzer, D. H., Apr-2018, In : Osteoporosis International. 29, 4, p. 813-824 12 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. The effect of bisphosphonates on bone mineral density in patients with ankylosing spondylitis in daily clinical practice

   Arends, S., Veneberg, J. G., Wink, F. R., Bos, R., Brouwer, E., Van Der Veer, E., Bootsma, H., Van Roon, E. N., Maas, F. & Spoorenberg, A., 1-Jun-2016, p. 821-822. 2 p.

   Research output: Contribution to conference › Poster › Academic

View all (96) »

1. Mastocytosis screening: use methylimidazole acetic acid in older overweight people

   Byrthe Vos, Eveline Veer, van der, Pieter Voorst Vader ,van, Andre Mulder, Sicco Heide, van der, Suzanne Boezerooij-Arends, Johanna Kluin-Nelemans, H. N. G. Oude Elberink, Jan Monchy ,de & Jasper Doormaal, van

   13/08/2014

   1 item of Media coverage

   Press/Media: Research › Popular

2. Diagnosed with indolent systemic mastocytosis: what’s my fragility fracture risk?

   Eveline Veer, van der

   27/06/2014

   1 item of Media coverage

   Press/Media: Research › Popular

3. Inzicht in therapietrouw bisfosfonaten

   Eveline Veer, van der

   19/12/2012

   1 item of Media coverage

   Press/Media: Research › Popular

View all (3) »